Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Danesh Kimia Pharmed is an Iranian pharmaceutical company focused on the synthesis of high-value Active Pharmaceutical Ingredients (APIs) and the production of finished dosage forms. The company specializes in cardiovascular medications, particularly modern oral anticoagulants such as Rivaroxaban and Dabigatran. Operating out of the Payam Special Economic Zone, Danesh Kimia Pharmed utilizes advanced chemical synthesis technologies to provide affordable alternatives to imported medicines. Their business model encompasses both the manufacturing of raw materials for other pharmaceutical firms and the marketing of their own branded generic products. The company maintains facilities that adhere to Good Manufacturing Practice (GMP) standards to ensure the quality of its chemical synthesis and formulation processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Danesh Kimia Pharmed.